Cell Biology – New Technology – Hands-on in Lab – Customer Collaboration
This is a new key position where you will develop new laboratory applications for novel cell biology instruments developed by AcouSort. They include AcouWash for cell washing and separation as well as AcouTrap for cell enrichment and assay automation.
AcouSort is a young high-tech biomedical engineering company developing microfluidic platforms for life science applications and medical diagnostics. We are a small team of dedicated engineers and are now seeking to expand our team with expertise in cell biology.
Your role offers a great opportunity to identify and develop new applications. You will be working directly with leading scientists and R&D departments in Sweden and abroad. Depending on your profile, there will be broad range of future career paths.
The Customer Application Specialist will report to CEO Torsten Freltoft.
The position as Customer Application Specialist is a full-time position located in Lund. The position will entail some travel to customers, conferences and trade shows (max. 30 days per year).
For further information regarding the position, please contact Birgit O’Sullivan (Tel +45 5122 1979, email@example.com).
Send your application with CV and relevant diplomas and references marked: ”Customer Application Specialist" to firstname.lastname@example.org. There is no fixed deadline, as there will be an ongoing assessment.
All enquiries and applications will of course be handled confidentially.
AcouSort AB is a biotech/medtech company based in Medicon Village, Lund. The company has developed a platform technology using acoustophoresis - an innovative microfluidic method to separate, wash and enrich cells and other particles for bioanalysis using ultrasound. Acousort develops instruments for the biology lab as well as collaborates with major life science to contribute to the diagnostic methods of the future. These technologies are used for research in diagnostics of diseases such as cancer and sepsis (blood poisoning) and has also developed critical care analysis systems.
AcouSort's technology and its R&D team are spun out from Lund University. The company collaborates closely with major international life science players.
AcouSort is jointly developing acoustophoresis for a broad range of clinical and medical applications. After a successful IPO, the company was listed on AktieTorget in January 2017.
For further information, see www.acousort.com.